EntryPoint Capital LLC Has $377,000 Stock Holdings in Maximus, Inc. (NYSE:MMS)

EntryPoint Capital LLC lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 40.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,045 shares of the health services provider’s stock after selling 3,387 shares during the quarter. EntryPoint Capital LLC’s holdings in Maximus were worth $377,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. UMB Bank n.a. boosted its holdings in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after buying an additional 158 shares during the last quarter. Eastern Bank acquired a new position in shares of Maximus in the fourth quarter valued at about $29,000. V Square Quantitative Management LLC increased its position in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after acquiring an additional 180 shares during the period. R Squared Ltd acquired a new stake in Maximus in the 4th quarter worth about $54,000. Finally, IFP Advisors Inc boosted its holdings in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Maximus Price Performance

Shares of NYSE:MMS opened at $66.97 on Thursday. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $3.79 billion, a PE ratio of 14.40 and a beta of 0.71. The firm has a 50 day moving average of $70.42 and a 200-day moving average of $78.09. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.79%. The ex-dividend date was Friday, February 14th. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.